WOUNDCHEK is a leading brand in the field of wound diagnostics, focused on developing innovative products to improve outcomes in wound care. With ineffective treatment costing an estimated $20-25 billion annually, there is a pressing need for accurate and efficient diagnostic solutions. Clinical experts agree that point-of-care wound diagnostic devices can significantly reduce the cost of ineffective treatment and delayed healing by enabling targeted therapy for the right patients at the right time.

WOUNDCHEK Laboratories has taken a pioneering step by introducing the world's first and only point-of-care test for detecting EPA (elevated protease activity) in wounds. This breakthrough technology allows healthcare professionals to identify and address the root cause of delayed wound healing, leading to improved patient outcomes. By utilizing WOUNDCHEK's diagnostic tests, healthcare systems can achieve substantial financial benefits through reduced expenses related to poor targeting of treatment, prolonged healing, and preventable complications.

WOUNDCHEK's mission is to revolutionize wound care by providing accurate, cost-effective, and timely diagnostic solutions